HMA-EMA joint Network Data Steering Group meeting - 6 October 2025
Submitted by Anonymous (not verified) on 3 December 2025 - 8:32
HMA-EMA joint Network Data Steering Group meeting - 6 October 2025
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 3 December 2025 - 8:18
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 3 December 2025 - 8:05
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 10, Status: Authorised
Agenda of the CAT meeting 3-5 December 2025
Submitted by Anonymous (not verified) on 3 December 2025 - 8:00
Agenda of the CAT meeting 3-5 December 2025
PSUSA/00002558/202501
Submitted by Anonymous (not verified) on 2 December 2025 - 16:08
PSUSA/00002558/202501
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 14:00 (CET) to 18 November 2025, 15:00 (CET)
Submitted by Anonymous (not verified) on 2 December 2025 - 15:40
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 14:00 (CET) to 18 November 2025, 15:00 (CET)
CAT quarterly highlights and approved ATMPs - December 2025
Submitted by Anonymous (not verified) on 2 December 2025 - 15:39
CAT quarterly highlights and approved ATMPs - December 2025
Opinion on medicine for use outside EU: Aluvia, lopinavir,ritonavir, HIV Infections, 21/09/2006 Positive opinion
Submitted by Anonymous (not verified) on 2 December 2025 - 15:17
Opinion on medicine for use outside EU: Aluvia, lopinavir,ritonavir, HIV Infections, 21/09/2006 Positive opinion
Outcomes of imposed non-interventional post-authorisation safety studies
Submitted by Anonymous (not verified) on 2 December 2025 - 15:10
Outcomes of imposed non-interventional post-authorisation safety studies
Human medicines European public assessment report (EPAR): Kaletra, lopinavir,ritonavir, Date of authorisation: 19/03/2001, Revision: 65, Status: Authorised
Submitted by Anonymous (not verified) on 2 December 2025 - 14:56
Human medicines European public assessment report (EPAR): Kaletra, lopinavir,ritonavir, Date of authorisation: 19/03/2001, Revision: 65, Status: Authorised